LSC
TNDM icon

Lyon Street Capital’s Tandem Diabetes Care TNDM Stock Holding History

Lyon Street Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$436K Sell
3,750
-4,250
-53% -$496K 0.65% 76
2021
Q4 		$1.2M Buy
+8,000
New +$1.08M 1.2% 36
2020
Q3 		$274K Buy
+2,412
New +$253K 0.82% 52

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Lyon Street Capital's TNDM Position: Q1 2022 in Review

Lyon Street Capital reduced its Tandem Diabetes Care (TNDM) stake by 53% in Q1 2022, selling an estimated $496K and leaving 3,750 shares worth $436K. The position accounts for 0.65% of the portfolio, ranked #76.

Lyon Street Capital first reported a position in TNDM in Q3 2020 and has held it in 3 quarters since. The position peaked at $1.2M in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Lyon Street Capital held 3,750 shares of Tandem Diabetes Care worth $436K as of Q1 2022.
  • Lyon Street Capital sold 4,250 Tandem Diabetes Care shares in Q1 2022, an estimated $496K.
  • Tandem Diabetes Care made up 0.65% of Lyon Street Capital's portfolio in Q1 2022, its #76 holding.
  • Lyon Street Capital first reported a position in Tandem Diabetes Care in Q3 2020 and has held it in 3 quarters since.
  • Lyon Street Capital's Tandem Diabetes Care position peaked at $1.2M in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Lyon Street Capital's 13F filing for Q1 2022, filed 16 May 2022.